{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:22Z","timestamp":1789628542806,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10196-1","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:47Z","timestamp":1787061647000},"page":"6100-6112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework"],"prefix":"10.1007","volume":"71","author":[{"given":"Khaled H.","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Bungish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"10196_CR1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066\u20132078. https:\/\/doi.org\/10.1056\/NEJMra0804647.","journal-title":"N Engl J Med"},{"key":"10196_CR2","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1186\/s12889-025-24009-z","volume":"25","author":"K Yang","year":"2025","unstructured":"Yang K, Zhang C, Gong R et al. From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios. BMC Public Health 2025;25:2696. https:\/\/doi.org\/10.1186\/s12889-025-24009-z.","journal-title":"BMC Public Health"},{"key":"10196_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12572","author":"F D\u2019Amico","year":"2024","unstructured":"D\u2019Amico F, Gomoll\u00f3n F, Bamias G et al. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study. United Eur Gastroenterol J. 2024. https:\/\/doi.org\/10.1002\/ueg2.12572.","journal-title":"United Eur Gastroenterol J"},{"key":"10196_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ibd\/izae119","volume":"31","author":"J Burisch","year":"2025","unstructured":"Burisch J, Hart A, Sturm A et al. Residual disease burden among European patients with inflammatory bowel disease: a real-world survey. Inflamm Bowel Dis 2025;31:411\u2013424. https:\/\/doi.org\/10.1093\/ibd\/izae119.","journal-title":"Inflamm Bowel Dis"},{"key":"10196_CR5","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S1470-2045(21)00639-2","volume":"23","author":"MI Printezi","year":"2022","unstructured":"Printezi MI, Kilgallen AB, Bond MJG et al. Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. Lancet Oncol 2022;23:e129\u2013e143. https:\/\/doi.org\/10.1016\/S1470-2045(21)00639-2.","journal-title":"Lancet Oncol"},{"key":"10196_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41416-024-02704-9","volume":"131","author":"A Karabou\u00e9","year":"2024","unstructured":"Karabou\u00e9 A, Innominato PF, Wreglesworth NI et al. Why does circadian timing of administration matter for immune checkpoint inhibitors\u2019 efficacy? Br J Cancer 2024;131:783\u2013796. https:\/\/doi.org\/10.1038\/s41416-024-02704-9.","journal-title":"Br J Cancer"},{"key":"10196_CR7","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2006.06.1440","volume":"24","author":"S Giacchetti","year":"2006","unstructured":"Giacchetti S, Bjarnason G, Garufi C et al. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European organisation for research and treatment of cancer chronotherapy group. J Clin Oncol 2006;24:3562\u20133569. https:\/\/doi.org\/10.1200\/JCO.2006.06.1440.","journal-title":"J Clin Oncol"},{"key":"10196_CR8","doi-asserted-by":"publisher","first-page":"CD009462","DOI":"10.1002\/14651858.CD009462.pub2","volume":"11","author":"JM Izquierdo-Palomares","year":"2016","unstructured":"Izquierdo-Palomares JM, Fernandez-Tabera JM, Plana MN et al. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia. Cochrane Database Syst Rev 2016;11:CD009462. https:\/\/doi.org\/10.1002\/14651858.CD009462.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"10196_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/ard.2009.126888","volume":"69","author":"F Buttgereit","year":"2010","unstructured":"Buttgereit F, Doering G, Schaeffler A et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis 2010;69:1275\u20131280. https:\/\/doi.org\/10.1136\/ard.2009.126888.","journal-title":"Ann Rheum Dis"},{"key":"10196_CR10","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1093\/jcag\/gwae027","volume":"8","author":"Z Post","year":"2025","unstructured":"Post Z, Zilberstein NF, Keshavarzian A. The circadian rhythm as therapeutic target in inflammatory bowel disease. J Can Assoc Gastroenterol 2025;8:S27\u2013S35. https:\/\/doi.org\/10.1093\/jcag\/gwae027.","journal-title":"J Can Assoc Gastroenterol"},{"key":"10196_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2025.06.017","volume":"169","author":"F Bishehsari","year":"2025","unstructured":"Bishehsari F, Post Z, Swanson GR, Keshavarzian A. Circadian rhythms in gastroenterology: the biological clock\u2019s impact on gut health. Gastroenterology 2025;169:1380\u20131396. https:\/\/doi.org\/10.1053\/j.gastro.2025.06.017.","journal-title":"Gastroenterology"},{"key":"10196_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/clockssleep5020021","volume":"5","author":"J Giebfried","year":"2023","unstructured":"Giebfried J, Lorentz A. Relationship between the biological clock and inflammatory bowel disease. Clocks Sleep 2023;5:260\u2013275. https:\/\/doi.org\/10.3390\/clockssleep5020021.","journal-title":"Clocks Sleep"},{"key":"10196_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/17474124.2019.1595588","volume":"13","author":"RM Voigt","year":"2019","unstructured":"Voigt RM, Forsyth CB, Keshavarzian A. Circadian rhythms: a regulator of gastrointestinal health and dysfunction. Expert Rev Gastroenterol Hepatol 2019;13:411\u2013424. https:\/\/doi.org\/10.1080\/17474124.2019.1595588.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10196_CR14","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/ijms26083724","volume":"26","author":"Y Nagao","year":"2025","unstructured":"Nagao Y, Taguchi A, Ohta Y. Circadian rhythm dysregulation in inflammatory bowel disease: mechanisms and chronotherapeutic approaches. Int J Mol Sci 2025;26:3724. https:\/\/doi.org\/10.3390\/ijms26083724.","journal-title":"Int J Mol Sci"},{"key":"10196_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/medicina61060995","volume":"61","author":"A Saviano","year":"2025","unstructured":"Saviano A, Candelli M, Brigida M et al. How shift work affects our gut microbiota: impact on gastrointestinal diseases. Medicina (Kaunas) 2025;61:995. https:\/\/doi.org\/10.3390\/medicina61060995.","journal-title":"Medicina (Kaunas)"},{"key":"10196_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102214","volume":"47","author":"C Zhang","year":"2023","unstructured":"Zhang C, Liu X. Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2023;47:102214. https:\/\/doi.org\/10.1016\/j.clinre.2023.102214.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10196_CR17","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1073\/pnas.1501305112","volume":"112","author":"X Liang","year":"2015","unstructured":"Liang X, Bushman FD, FitzGerald GA. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Natl Acad Sci USA 2015;112:10479\u201310484. https:\/\/doi.org\/10.1073\/pnas.1501305112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10196_CR18","doi-asserted-by":"publisher","first-page":"1239278","DOI":"10.3389\/fphys.2023.1239278","volume":"14","author":"TJ Hibberd","year":"2023","unstructured":"Hibberd TJ, Ramsay S, Spencer-Merris P et al. Circadian rhythms in colonic function. Front Physiol 2023;14:1239278. https:\/\/doi.org\/10.3389\/fphys.2023.1239278.","journal-title":"Front Physiol"},{"key":"10196_CR19","doi-asserted-by":"publisher","first-page":"2453019","DOI":"10.1080\/19490976.2025.2453019","volume":"17","author":"HK Ruple","year":"2025","unstructured":"Ruple HK, Haasis E, Bettenburg A et al. The gut microbiota predicts and time-restricted feeding delays experimental colitis. Gut Microbes 2025;17:2453019. https:\/\/doi.org\/10.1080\/19490976.2025.2453019.","journal-title":"Gut Microbes"},{"key":"10196_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-024-01189-z","volume":"21","author":"Y Niu","year":"2024","unstructured":"Niu Y, Heddes M, Altaha B et al. Targeting the intestinal circadian clock by meal timing ameliorates gastrointestinal inflammation. Cell Mol Immunol 2024;21:842\u2013855. https:\/\/doi.org\/10.1038\/s41423-024-01189-z.","journal-title":"Cell Mol Immunol"},{"key":"10196_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apha.12090","volume":"208","author":"J P\u00e1cha","year":"2013","unstructured":"P\u00e1cha J, Sumov\u00e1 A. Circadian regulation of epithelial functions in the intestine. Acta Physiol (Oxf) 2013;208:11\u201324. https:\/\/doi.org\/10.1111\/apha.12090.","journal-title":"Acta Physiol (Oxf)"},{"key":"10196_CR22","doi-asserted-by":"publisher","first-page":"1043783","DOI":"10.3389\/fnut.2022.1043783","volume":"9","author":"S Song","year":"2022","unstructured":"Song S, Chen L, Bai M et al. Time-restricted feeding ameliorates dextran sulfate sodium-induced colitis via reducing intestinal inflammation. Front Nutr 2022;9:1043783. https:\/\/doi.org\/10.3389\/fnut.2022.1043783.","journal-title":"Front Nutr"},{"key":"10196_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098016","volume":"9","author":"O-O Kyoko","year":"2014","unstructured":"Kyoko O-O, Kono H, Ishimaru K et al. Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis. PLoS One 2014;9:e98016. https:\/\/doi.org\/10.1371\/journal.pone.0098016.","journal-title":"PLoS One"},{"key":"10196_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2012.05.021","volume":"37","author":"C Scheiermann","year":"2012","unstructured":"Scheiermann C, Kunisaki Y, Lucas D et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 2012;37:290\u2013301. https:\/\/doi.org\/10.1016\/j.immuni.2012.05.021.","journal-title":"Immunity"},{"key":"10196_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1042\/CS20256383","volume":"139","author":"O Froy","year":"2025","unstructured":"Froy O, Weintraub Y. The circadian clock, metabolism, and inflammation-the holy trinity of inflammatory bowel diseases. Clin Sci (Lond) 2025;139:777\u2013790. https:\/\/doi.org\/10.1042\/CS20256383.","journal-title":"Clin Sci (Lond)"},{"key":"10196_CR26","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1084\/jem.20160723","volume":"213","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Hayano Y, Nakai A et al. Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J Exp Med 2016;213:2567\u20132574. https:\/\/doi.org\/10.1084\/jem.20160723.","journal-title":"J Exp Med"},{"key":"10196_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11882-020-0896-9","volume":"20","author":"SN Waggoner","year":"2020","unstructured":"Waggoner SN. Circadian rhythms in immunity. Curr Allergy Asthma Rep 2020;20:2. https:\/\/doi.org\/10.1007\/s11882-020-0896-9.","journal-title":"Curr Allergy Asthma Rep"},{"key":"10196_CR28","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/nu16081236","volume":"16","author":"A Jurjus","year":"2024","unstructured":"Jurjus A, El Masri J, Ghazi M et al. Mechanism of action of melatonin as a potential adjuvant therapy in inflammatory bowel disease and colorectal cancer. Nutrients 2024;16:1236. https:\/\/doi.org\/10.3390\/nu16081236.","journal-title":"Nutrients"},{"key":"10196_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2014.02.002","volume":"40","author":"AM Curtis","year":"2014","unstructured":"Curtis AM, Bellet MM, Sassone-Corsi P, O\u2019Neill LAJ. Circadian clock proteins and immunity. Immunity 2014;40:178\u2013186. https:\/\/doi.org\/10.1016\/j.immuni.2014.02.002.","journal-title":"Immunity"},{"key":"10196_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122814","volume":"351","author":"X Xie","year":"2024","unstructured":"Xie X, Zhang M, Luo H. Regulation of metabolism by circadian rhythms: Support from time-restricted eating, intestinal microbiota & omics analysis. Life Sci 2024;351:122814. https:\/\/doi.org\/10.1016\/j.lfs.2024.122814.","journal-title":"Life Sci"},{"key":"10196_CR31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.cgh.2013.01.021","volume":"11","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Long MD, Martin CF et al. Sleep disturbance and risk of active disease in patients with Crohn\u2019s disease and ulcerative colitis. Clin Gastroenterol Hepatol 2013;11:965\u2013971. https:\/\/doi.org\/10.1016\/j.cgh.2013.01.021.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10196_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.770491","volume":"8","author":"GR Swanson","year":"2021","unstructured":"Swanson GR, Kochman N, Amin J et al. Disrupted circadian rest-activity cycles in inflammatory bowel disease are associated with aggressive disease phenotype, subclinical inflammation, and dysbiosis. Front Med (Lausanne) 2021;8:770491. https:\/\/doi.org\/10.3389\/fmed.2021.770491.","journal-title":"Front Med (Lausanne)"},{"key":"10196_CR33","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/j.1440-1746.2006.04820.x","volume":"22","author":"Z Ranjbaran","year":"2007","unstructured":"Ranjbaran Z, Keefer L, Farhadi A et al. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 2007;22:1748\u20131753. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04820.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"10196_CR34","doi-asserted-by":"publisher","first-page":"A89","DOI":"10.1136\/gutjnl-2025-IDDF.49","volume-title":"Basic gastroenterology","author":"J Liu","year":"2025","unstructured":"Liu J, Luan F, Feng Z et al. IDDF2025-ABS-0040 Downregulation of circadian gene expression in patients with inflammatory bowel disease and its association with the severity of inflammation. In BMJ Publishing Group; 2025; A89\u2013A90."},{"key":"10196_CR35","doi-asserted-by":"publisher","first-page":"i2322","DOI":"10.1093\/ecco-jcc\/jjae190.1462","volume":"19","author":"J Zhao","year":"2025","unstructured":"Zhao J, Xue E, Yu G et al. P1288 the association of long-term night shift work and related circulating proteins with inflammatory bowel disease: A prospective cohort and multi-omics study. J Crohns Colitis 2025;19:i2322\u2013i2322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae190.1462.","journal-title":"J Crohns Colitis"},{"key":"10196_CR36","doi-asserted-by":"publisher","first-page":"1424926","DOI":"10.3389\/fmed.2024.1424926","volume":"11","author":"M Truyens","year":"2024","unstructured":"Truyens M, Lernout H, De Vos M et al. Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis. Front Med (Lausanne) 2024;11:1424926. https:\/\/doi.org\/10.3389\/fmed.2024.1424926.","journal-title":"Front Med (Lausanne)"},{"key":"10196_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2025.112199","volume":"195","author":"HM Sonbol","year":"2025","unstructured":"Sonbol HM, El-Sayed MM, Khedr MA et al. Type D personality, insomnia severity, perceived stress, and health-related quality of life in inflammatory bowel disease: a case-control study. J Psychosom Res 2025;195:112199. https:\/\/doi.org\/10.1016\/j.jpsychores.2025.112199.","journal-title":"J Psychosom Res"},{"key":"10196_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ibd\/izy334","volume":"25","author":"T Qazi","year":"2019","unstructured":"Qazi T, Farraye FA. Sleep and inflammatory bowel disease: an important bi-directional relationship. Inflamm Bowel Dis 2019;25:843\u2013852. https:\/\/doi.org\/10.1093\/ibd\/izy334.","journal-title":"Inflamm Bowel Dis"},{"key":"10196_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5217\/ir.2023.00028","volume":"22","author":"A Barnes","year":"2024","unstructured":"Barnes A, Andrews JM, Mukherjee S et al. Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intest Res 2024;22:104\u2013114. https:\/\/doi.org\/10.5217\/ir.2023.00028.","journal-title":"Intest Res"},{"key":"10196_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1586\/eci.10.83","volume":"7","author":"GR Swanson","year":"2011","unstructured":"Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol 2011;7:29\u201336. https:\/\/doi.org\/10.1586\/eci.10.83.","journal-title":"Expert Rev Clin Immunol"},{"key":"10196_CR41","doi-asserted-by":"publisher","first-page":"e00549","DOI":"10.14309\/ctg.0000000000000549","volume":"14","author":"GR Swanson","year":"2023","unstructured":"Swanson GR, Biglin M, Raff H et al. Impact of chronotherapy on 6-mercaptopurine metabolites in inflammatory bowel disease: a pilot crossover trial. Clin Transl Gastroenterol 2023;14:e00549. https:\/\/doi.org\/10.14309\/ctg.0000000000000549.","journal-title":"Clin Transl Gastroenterol"},{"key":"10196_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2020.00155","volume":"20","author":"A Singh","year":"2022","unstructured":"Singh A, Mahajan R, Kedia S et al. Use of thiopurines in inflammatory bowel disease: an update. Intest Res 2022;20:11\u201330. https:\/\/doi.org\/10.5217\/ir.2020.00155.","journal-title":"Intest Res"},{"key":"10196_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/DDDT.S11290","volume":"5","author":"JK Triantafillidis","year":"2011","unstructured":"Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther 2011;5:185\u2013210. https:\/\/doi.org\/10.2147\/DDDT.S11290.","journal-title":"Drug Des Devel Ther"},{"key":"10196_CR44","doi-asserted-by":"publisher","first-page":"i1703","DOI":"10.1093\/ecco-jcc\/jjae190.1075","volume":"19","author":"Z Post","year":"2025","unstructured":"Post Z, Maniak A, DeMeo A, Keshavarzian A. P0901 Infliximab chronotherapy: timing of intravenous infliximab administration affects inflammatory markers and clinical outcomes in inflammatory bowel disease. J Crohns Colitis 2025;19:i1703\u2013i1704. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae190.1075.","journal-title":"J Crohns Colitis"},{"key":"10196_CR45","doi-asserted-by":"publisher","first-page":"S972","DOI":"10.14309\/01.ajg.0001034812.41645.a7","volume":"119","author":"Z Post","year":"2024","unstructured":"Post Z, Maniak A, Demeo A, Keshavarzian A. S1361 evening timing of inpatient intravenous infliximab administration is associated with worse disease outcomes. Am J Gastroenterol 2024;119:S972\u2013S972. https:\/\/doi.org\/10.14309\/01.ajg.0001034812.41645.a7.","journal-title":"Am J Gastroenterol"},{"key":"10196_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5217\/ir.2019.00093","volume":"18","author":"YS Park","year":"2020","unstructured":"Park YS, Kim SH, Park JW et al. Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. Intest Res 2020;18:325\u2013336. https:\/\/doi.org\/10.5217\/ir.2019.00093.","journal-title":"Intest Res"},{"key":"10196_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.22037\/ijpr.2020.113822.14508","volume":"20","author":"S Shahrokh","year":"2021","unstructured":"Shahrokh S, Qobadighadikolaei R, Abbasinazari M et al. Efficacy and safety of melatonin as an adjunctive therapy on clinical, biochemical, and quality of life in patients with ulcerative colitis. Iran J Pharm Res 2021;20:197\u2013205. https:\/\/doi.org\/10.22037\/ijpr.2020.113822.14508.","journal-title":"Iran J Pharm Res"},{"key":"10196_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12876-024-03263-2","volume":"24","author":"S Cohen-Mekelburg","year":"2024","unstructured":"Cohen-Mekelburg S, Goldstein CA, Rizvydeen M et al. Morning light treatment for inflammatory bowel disease: a clinical trial. BMC Gastroenterol 2024;24:179. https:\/\/doi.org\/10.1186\/s12876-024-03263-2.","journal-title":"BMC Gastroenterol"},{"key":"10196_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/2042018810380214","volume":"1","author":"S Chan","year":"2010","unstructured":"Chan S, Debono M. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Ther Adv Endocrinol Metab 2010;1:129\u2013138. https:\/\/doi.org\/10.1177\/2042018810380214.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10196_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/07487304221131114","volume":"38","author":"TD Butler","year":"2023","unstructured":"Butler TD, Mohammed Ali A, Gibbs JE, McLaughlin JT. Chronotype in patients with immune-mediated inflammatory disease: a systematic review. J Biol Rhythms 2023;38:34\u201343. https:\/\/doi.org\/10.1177\/07487304221131114.","journal-title":"J Biol Rhythms"},{"key":"10196_CR51","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3748\/wjg.v17.i9.1095","volume":"17","author":"S De Iudicibus","year":"2011","unstructured":"De Iudicibus S, Franca R, Martelossi S et al. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011;17:1095\u20131108. https:\/\/doi.org\/10.3748\/wjg.v17.i9.1095.","journal-title":"World J Gastroenterol"},{"key":"10196_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2019.02.004","volume":"151\u2013152","author":"ML Scherholz","year":"2019","unstructured":"Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of glucocorticoids. Adv Drug Deliv Rev 2019;151\u2013152:245\u2013261. https:\/\/doi.org\/10.1016\/j.addr.2019.02.004.","journal-title":"Adv Drug Deliv Rev"},{"key":"10196_CR53","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2147\/tcrm.s112685","volume":"12","author":"S Beltrametti","year":"2016","unstructured":"Beltrametti S, Ianniello A, Ricci C. Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review. Ther Clin Risk Manag 2016;12:1763\u20131776. https:\/\/doi.org\/10.2147\/tcrm.s112685.","journal-title":"Ther Clin Risk Manag"},{"key":"10196_CR54","first-page":"S42","volume":"29","author":"CM Spies","year":"2011","unstructured":"Spies CM, Cutolo M, Straub RH et al. Prednisone chronotherapy. Clin Exp Rheumatol 2011;29:S42\u2013S45.","journal-title":"Clin Exp Rheumatol"},{"key":"10196_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2125.2005.02517.x","volume":"61","author":"M Brunner","year":"2006","unstructured":"Brunner M, Ziegler S, Di Stefano AFD et al. Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol 2006;61:31\u201338. https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02517.x.","journal-title":"Br J Clin Pharmacol"},{"key":"10196_CR56","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/gutjnl-2012-304258","volume":"63","author":"SPL Travis","year":"2014","unstructured":"Travis SPL, Danese S, Kupcinskas L et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut 2014;63:433\u2013441. https:\/\/doi.org\/10.1136\/gutjnl-2012-304258.","journal-title":"Gut"},{"key":"10196_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.crohns.2009.09.007","volume":"4","author":"GR D\u2019Haens","year":"2010","unstructured":"D\u2019Haens GR, Kov\u00e1cs A, Vergauwe P et al. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX\u00ae 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. J Crohns Colitis 2010;4:153\u2013160. https:\/\/doi.org\/10.1016\/j.crohns.2009.09.007.","journal-title":"J Crohns Colitis"},{"key":"10196_CR58","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","volume":"74","author":"GW Moran","year":"2025","unstructured":"Moran GW, Gordon M, Sinopolou V et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut 2025;74:s1\u2013s101. https:\/\/doi.org\/10.1136\/gutjnl-2024-334395.","journal-title":"Gut"},{"key":"10196_CR59","first-page":"4","volume":"6","author":"CA Sninsky","year":"2010","unstructured":"Sninsky CA. New research in ulcerative colitis: Optimizing 5-ASA administration for efficacy and adherence. Gastroenterol Hepatol (N Y) 2010;6:4\u201316.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10196_CR60","doi-asserted-by":"publisher","first-page":"CD000543","DOI":"10.1002\/14651858.CD000543.pub5","volume":"8","author":"A Murray","year":"2020","unstructured":"Murray A, Nguyen TM, Parker CE et al. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;8:CD000543. https:\/\/doi.org\/10.1002\/14651858.CD000543.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"10196_CR61","doi-asserted-by":"publisher","first-page":"1296.e1","DOI":"10.1053\/j.gastro.2009.12.054","volume":"138","author":"WJ Sandborn","year":"2010","unstructured":"Sandborn WJ, Korzenik J, Lashner B et al. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology 2010;138:1296.e1\u20133. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.054.","journal-title":"Gastroenterology"},{"key":"10196_CR62","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3389\/fimmu.2020.01783","volume":"11","author":"TD Butler","year":"2020","unstructured":"Butler TD, Gibbs JE. Circadian host-microbiome interactions in immunity. Front Immunol 2020;11:1783. https:\/\/doi.org\/10.3389\/fimmu.2020.01783.","journal-title":"Front Immunol"},{"key":"10196_CR63","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.18632\/oncotarget.13715","volume":"8","author":"X Qiu","year":"2017","unstructured":"Qiu X, Ma J, Wang K, Zhang H. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget 2017;8:1031\u20131045. https:\/\/doi.org\/10.18632\/oncotarget.13715.","journal-title":"Oncotarget"},{"key":"10196_CR64","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1171641","volume":"324","author":"KM Ramsey","year":"2009","unstructured":"Ramsey KM, Yoshino J, Brace CS et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009;324:651\u2013654. https:\/\/doi.org\/10.1126\/science.1171641.","journal-title":"Science"},{"key":"10196_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-9-1","volume":"9","author":"Y Nakahata","year":"2008","unstructured":"Nakahata Y, Yoshida M, Takano A et al. A direct repeat of E-box-like elements is required for cell-autonomous circadian rhythm of clock genes. BMC Mol Biol 2008;9:1. https:\/\/doi.org\/10.1186\/1471-2199-9-1.","journal-title":"BMC Mol Biol"},{"key":"10196_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5223\/pghn.2013.16.2.65","volume":"16","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Choe YH. Monitoring and safety of azathioprine therapy in inflammatory bowel disease. Pediatr Gastroenterol Hepatol Nutr 2013;16:65\u201370. https:\/\/doi.org\/10.5223\/pghn.2013.16.2.65.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10196_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003326","volume":"95","author":"Z Fangbin","year":"2016","unstructured":"Fangbin Z, Xiang G, Liang D et al. Prospective evaluation of pharmacogenomics and metabolite measurements upon azathioprine therapy in inflammatory bowel disease: an observational study. Medicine (Baltimore) 2016;95:e3326. https:\/\/doi.org\/10.1097\/MD.0000000000003326.","journal-title":"Medicine (Baltimore)"},{"key":"10196_CR68","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1440-1746.2005.03832.x","volume":"20","author":"RB Gearry","year":"2005","unstructured":"Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005;20:1149\u20131157. https:\/\/doi.org\/10.1111\/j.1440-1746.2005.03832.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"10196_CR69","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s1542-3565(04)00344-1","volume":"2","author":"MC Dubinsky","year":"2004","unstructured":"Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731\u2013743. https:\/\/doi.org\/10.1016\/s1542-3565(04)00344-1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10196_CR70","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1007\/s10067-025-07646-y","volume":"44","author":"CB Prasad","year":"2025","unstructured":"Prasad CB, Dhir V, Gupta R et al. Split vs single-dose oral methotrexate in rheumatoid arthritis: a randomized controlled trial (SMART study). Clin Rheumatol 2025;44:3869\u20133879. https:\/\/doi.org\/10.1007\/s10067-025-07646-y.","journal-title":"Clin Rheumatol"},{"key":"10196_CR71","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.3748\/wjg.v12.i23.3657","volume":"12","author":"M Pierik","year":"2006","unstructured":"Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006;12:3657\u20133667. https:\/\/doi.org\/10.3748\/wjg.v12.i23.3657.","journal-title":"World J Gastroenterol"},{"key":"10196_CR72","doi-asserted-by":"publisher","first-page":"i1540","DOI":"10.1093\/ecco-jcc\/jjae190.0978","volume":"19","author":"I Odeyemi","year":"2025","unstructured":"Odeyemi I, Baum K, Colombel JF et al. P0804 Morning administration of biologic therapy is associated with decreased risk of treatment failure in patients with Inflammatory Bowel Disease. J Crohns Colitis 2025;19:i1540\u2013i1541. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae190.0978.","journal-title":"J Crohns Colitis"},{"key":"10196_CR73","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.drudis.2021.03.015","volume":"26","author":"RFN Ribeiro","year":"2021","unstructured":"Ribeiro RFN, Cavadas C, Silva MMC. Small-molecule modulators of the circadian clock: pharmacological potentials in circadian-related diseases. Drug Discov Today 2021;26:1620\u20131641. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.015.","journal-title":"Drug Discov Today"},{"key":"10196_CR74","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13075-025-03555-2","volume":"27","author":"T Hashimoto","year":"2025","unstructured":"Hashimoto T, Tsuboi K, Abe T et al. Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study. Arthritis Res Ther 2025;27:91. https:\/\/doi.org\/10.1186\/s13075-025-03555-2.","journal-title":"Arthritis Res Ther"},{"key":"10196_CR75","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/pharmaceutics13111915","volume":"13","author":"L Dobrek","year":"2021","unstructured":"Dobrek L. Chronopharmacology in Therapeutic Drug Monitoring-dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood. Pharmaceutics 2021;13:1915. https:\/\/doi.org\/10.3390\/pharmaceutics13111915.","journal-title":"Pharmaceutics"},{"key":"10196_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178782","volume":"12","author":"D Fischer","year":"2017","unstructured":"Fischer D, Lombardi DA, Marucci-Wellman H, Roenneberg T. Chronotypes in the US - Influence of age and sex. PLoS One 2017;12:e0178782. https:\/\/doi.org\/10.1371\/journal.pone.0178782.","journal-title":"PLoS One"},{"key":"10196_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/0748730412475041","volume":"28","author":"M Juda","year":"2013","unstructured":"Juda M, Vetter C, Roenneberg T. The Munich ChronoType Questionnaire for shift-workers (MCTQShift). J Biol Rhythms 2013;28:130\u2013140. https:\/\/doi.org\/10.1177\/0748730412475041.","journal-title":"J Biol Rhythms"},{"key":"10196_CR78","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/0748730415597520","volume":"30","author":"T Kantermann","year":"2015","unstructured":"Kantermann T, Sung H, Burgess HJ. Comparing the Morningness-eveningness questionnaire and Munich chronotype questionnaire to the dim light melatonin onset. J Biol Rhythms 2015;30:449\u2013453. https:\/\/doi.org\/10.1177\/0748730415597520.","journal-title":"J Biol Rhythms"},{"key":"10196_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1081\/cbi-200053536","volume":"22","author":"A Zavada","year":"2005","unstructured":"Zavada A, Gordijn MCM, Beersma DGM et al. Comparison of the munich chronotype questionnaire with the Horne-\u00d6stberg\u2019s Morningness-Eveningness score. Chronobiol Int 2005;22:267\u2013278. https:\/\/doi.org\/10.1081\/cbi-200053536.","journal-title":"Chronobiol Int"},{"key":"10196_CR80","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/07487304211044301","volume":"36","author":"Y Lee","year":"2021","unstructured":"Lee Y, Field JM, Sehgal A. Circadian rhythms, disease and chronotherapy. J Biol Rhythms 2021;36:503\u2013531. https:\/\/doi.org\/10.1177\/07487304211044301.","journal-title":"J Biol Rhythms"},{"key":"10196_CR81","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/17512433.2023.2233438","volume":"16","author":"A Fujimura","year":"2023","unstructured":"Fujimura A, Ushijima K. Understanding the role of chronopharmacology for drug optimization: what do we know? Expert Rev Clin Pharmacol 2023;16:655\u2013668. https:\/\/doi.org\/10.1080\/17512433.2023.2233438.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10196_CR82","doi-asserted-by":"publisher","first-page":"20219","DOI":"10.1021\/acs.jafc.5c05176","volume":"73","author":"Q Qian","year":"2025","unstructured":"Qian Q, Luan W, Ma J et al. Beneficial effects of apple polyphenol extract and time-restricted feeding on ulcerative colitis and accompanying depression-like behaviors are correlated with gut-brain axis modulation. J Agric Food Chem 2025;73:20219\u201320234. https:\/\/doi.org\/10.1021\/acs.jafc.5c05176.","journal-title":"J Agric Food Chem"},{"key":"10196_CR83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/07420528.2018.1527773","volume":"36","author":"L T\u00e4hk\u00e4m\u00f6","year":"2019","unstructured":"T\u00e4hk\u00e4m\u00f6 L, Partonen T, Pesonen A-K. Systematic review of light exposure impact on human circadian rhythm. Chronobiol Int 2019;36:151\u2013170. https:\/\/doi.org\/10.1080\/07420528.2018.1527773.","journal-title":"Chronobiol Int"},{"key":"10196_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2025.112149","volume":"194","author":"Suhardita K Ulfah","year":"2025","unstructured":"Ulfah Suhardita K, Saputra R et al. Circadian rhythms and health: Chronobiological strategies for enhancing physical and mental well-being. J Psychosom Res 2025;194:112149. https:\/\/doi.org\/10.1016\/j.jpsychores.2025.112149.","journal-title":"J Psychosom Res"},{"key":"10196_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2024.101953","volume":"76","author":"O Saidi","year":"2024","unstructured":"Saidi O, Rochette E, Dambel L et al. Chrono-nutrition and sleep: lessons from the temporal feature of eating patterns in human studies - A systematic scoping review. Sleep Med Rev 2024;76:101953. https:\/\/doi.org\/10.1016\/j.smrv.2024.101953.","journal-title":"Sleep Med Rev"},{"key":"10196_CR86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-pharmtox-051920-095416","volume":"64","author":"FA L\u00e9vi","year":"2024","unstructured":"L\u00e9vi FA, Okyar A, Hadadi E et al. Circadian regulation of drug responses: toward sex-specific and personalized chronotherapy. Annu Rev Pharmacol Toxicol 2024;64:89\u2013114. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051920-095416.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10196_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/amsr.amsr_13_23","volume":"2","author":"M Sharma","year":"2023","unstructured":"Sharma M, Kumar H, Nautiyal A, Kumar B. An insight on chronopharmacology and its application in pharmacotherapy. Ann Med Sci Res 2023;2:139\u2013143. https:\/\/doi.org\/10.4103\/amsr.amsr_13_23.","journal-title":"Ann Med Sci Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10196-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:07:52Z","timestamp":1789625272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10196-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":87,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10196"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10196-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}